Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Healthcare Editor
UK
23+ years of experience
In Vivo
By Ashley Yeo 28 Dec 2021
At the end of a turbulent year for health care, COVID-19 is still dominating the thoughts of stakeholders, but CMS patent attorneys Jane Hollywood and Rob Stephen are encouraged by the innovation and investment trends that are making it an exciting time to be in the thick of the action.
Medtech Insight
By Ashley Yeo 23 Apr 2021
The UK’s new medical device registration system, one element of the post-Brexit transition being overseen by the MHRA, is going more or less to plan in the early stages of the standstill period.
Medtech Insight
By Ashley Yeo 27 Nov 2020
Germany’s authorities are back on guard against COVID-19 following renewed regional outbreaks. Diagnostics manufacturers will continue to play a strong part in bringing the pandemic substantially under control, a recent industry association virtual conference heard.
Medtech Insight
By Ashley Yeo 27 Nov 2020
Although the EU MDR and IVDR will fall outside the scope of new post-Brexit medtech regulations for Great Britain in 2021, the UK MHRA says it has the chance of developing its own world-leading regulatory regime.
Topic Medtech-Brexit Regulation Brexit
Medtech Insight
By Ashley Yeo 23 Nov 2020
BVMed says the EU and the UK should set up a system of mutual recognition of medical device regulation to kick in when the UK’s EU exit transition period ends on 31 December.
Topic Medtech-Brexit Regulation Brexit
Medtech Insight
By Ashley Yeo 23 Nov 2020
The UK will have new regulatory systems for medical devices in place for when it leaves the EU at the end of this year. The Office for Life Sciences has been fielding more questions from industry on the new structures.
Topic Medtech-Brexit Regulation Brexit
Medtech Insight
By Ashley Yeo 21 Oct 2020
How coronavirus affects IVDs businesses depends on the branch of the industry they are in, a German survey of manufacturers shows. German labs performed one million COVID-19 tests last week.
Topic Coronavirus EU Policy & Regulation
Medtech Insight
By Ashley Yeo 26 Aug 2020
COVID-19 is of no lesser importance to the UK medtech industry, but attention is now refocusing on Brexit, future regulation and trade deals.
Topic EU Medtech-Brexit
Medtech Insight
By Ashley Yeo 26 Aug 2020
Work has started on UK-only regulations for the medtech and medicines sectors, to ensure that the regulatory framework not only functions but can also react swiftly to needs after the UK leaves the EU. This article is part two of two.
Topic EU Medtech-Brexit Regulation Brexit
Medtech Insight
By Ashley Yeo 25 Aug 2020
The second round of the UK’s talks on exiting the EU by the end of the year have been called off over COVID-19, but whether this is a temporary derailment or a more structural issue for the UK’s planned EU separation is the question emerging.
Topic Brexit
In Vivo
By Ashley Yeo 11 Dec 2019
For providers and medtech manufacturers alike, the decade ahead will be a time of coming to terms with digital technologies and integrating new methods of payment. Quality of service delivery remains the market entry criterion, but companies will have to adapt to evolving health care delivery models. The stakes are implausibly high. Will they be able to capitalize on the changes in a market that is more competitive and unpredictable than ever?
Topic Market Intelligence Outlook
In Vivo
By Ashley Yeo 12 Jul 2019
Medtech’s contribution to health care improvements in Europe over the past 30 years has been a phenomenal journey of success – in patient terms as well as in commercial terms, says MedTech Europe chair Rob ten Hoedt. Local creativity has been able to mine a seam of product innovation that is unmatched anywhere in the world, but the sector is facing massive change and must find ways to cope.
Topic Medtech Digital Health
In Vivo
By Ashley Yeo 11 Jun 2019
Value is a concept that is increasingly embraced by providers and payers, as well as medtech manufacturers. Leading providers are organizing around value, changing their models and thereby inviting medtech manufacturers to adapt to the post fee-for-service era. Some, like Medtronic, are at the head of the game.
In Vivo
By Ashley Yeo 10 Jun 2019
Drug delivery technology specialist Consort Medical has capitalized on device respiratory expertise for 50 years, but a renewed focus on strategic expansion has seen it make an IP play, move into the pharma side and target other delivery formats for global pharma industry customers. Its enhanced capabilities will keep rivals on their toes.
Topic Drug Review Approvals
In Vivo
By Ashley Yeo 22 Aug 2018
The health products industry, methods of care delivery and even the public's expectations for improved tools to prevent, monitor and treat disease have transformed dramatically in the past five years. The changes anticipated over a similar period ahead are potentially even more marked, with business continuity impacts for medtech and pharma concerns, according to Deloitte LLP experts who were on the circuit at health care industry events in Germany and the UK this spring.
In Vivo
13 Jul 2022
Medtech Insight
06 Jul 2022
Medtech Insight
24 Jun 2022
Medtech Insight
23 Jun 2022
Medtech Insight
22 Jun 2022
In Vivo
21 Jun 2022
Medtech Insight
17 Jun 2022
Medtech Insight
08 Jun 2022
Medtech Insight
01 Jun 2022
Medtech Insight
17 May 2022
In Vivo
21 Apr 2022
In Vivo
13 Apr 2022
Medtech Insight
01 Apr 2022
Medtech Insight
23 Mar 2022
Medtech Insight
18 Mar 2022
